Patent · US Active

Tripartite oligonucleotide complexes and methods for gene silencing by RNA interference

US8809514B2 · kind B2 · utility

10Cited by
0References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 20, 2007
Grant dateAug 19, 2014
Priority date
Expiry dateMay 1, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2330/30
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided herein are tripartite oligonucleotide complexes which can be administered to a cell, tissue or organism to silence a target gene. The tripartite oligonucleotide complexes of the disclosure may include a conjugate moiety that facilitates delivery to a cell, tissue or organism without the aid of a transfection reagent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.